Trial intelligence / Profile preview

Clopidogrel in Peri-Operative General Surgery

NCT01960296Phase 2Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Jan 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of clopidogrel in thrombosis, myocardial infarction (MI), sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2012; status: completed.

02

Drugs

clopidogrel
03

Conditions

thrombosismyocardial infarction (MI)

Beyond the preview

Go deeper on NCT01960296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01960296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call